What are the differences between Humulin N (NPH insulin) and Humulin 70/30 (70% NPH and 30% regular insulin) regarding composition, dosing schedule, and clinical use?

Humulin N vs 70/30: Key Differences and Clinical Selection

Humulin N (NPH insulin) is pure intermediate-acting basal insulin dosed once or twice daily for fasting glucose control, while Humulin 70/30 is a premixed formulation (70% NPH + 30% regular insulin) that provides both basal and prandial coverage, typically dosed twice daily before meals.

Composition

Humulin N:

• 100% NPH (neutral protamine Hagedorn) insulin
• Pure intermediate-acting insulin
• Contains protamine to delay absorption

Humulin 70/30:

• 70% NPH insulin (intermediate-acting)
• 30% regular human insulin (short-acting)
• Fixed-ratio premixed formulation 1

Pharmacodynamics and Timing

Humulin N:

• Onset: Variable, intermediate-acting profile
• Used primarily for basal (fasting) glucose control
• Dosed once at bedtime OR twice daily (morning and evening) 2

Humulin 70/30:

• Onset: ~50 minutes (range 30-90 minutes)
• Peak effect: ~3.5 hours (range 1.5-6.5 hours)
• Duration: ~23 hours (range 18-24 hours)
• Peak serum concentration: 2.2 hours 1
• Provides both basal AND prandial (mealtime) coverage due to the regular insulin component

Clinical Use Algorithm

Choose Humulin N when:

• Patient needs basal insulin only (already on separate prandial insulin or oral agents)
• Flexibility in dosing adjustments is required—NPH can be titrated independently
• Converting from bedtime NPH: start 10 units/day or 0.1-0.2 units/kg/day, titrate by 2 units every 3 days to reach fasting glucose goal 2
• Patient has steroid-induced hyperglycemia (consider morning dosing) 2

Choose Humulin 70/30 when:

• Patient needs both basal and prandial coverage in a single injection
• Simplifying regimen is priority (fewer injections than separate basal-bolus)
• Patient is transitioning from twice-daily NPH and needs prandial coverage added 2
• Typical dosing: 2/3 of total daily dose before breakfast, 1/3 before dinner 2

Transitioning Between Regimens

From bedtime NPH to twice-daily NPH or premixed 70/30:

• Reduce total NPH dose to 80% of current bedtime dose
• Add 4 units of short/rapid-acting insulin to each injection OR 10% of reduced NPH dose
• If A1C <8%, consider lowering basal dose by 4 units/day or 10% 2

Key advantage of 70/30: Reduces injection burden when adding prandial coverage to NPH—instead of separate injections, the premixed formulation combines both 2

Critical Clinical Considerations

Hypoglycemia risk:

• Both carry hypoglycemia risk, but 70/30 has additional risk from the regular insulin component
• If hypoglycemia occurs without clear cause, reduce dose by 10-20% 2
• Consider switching from evening NPH to basal analog if recurrent hypoglycemia develops 2

Flexibility trade-off:

• Humulin N allows independent titration of basal insulin
• Humulin 70/30 cannot separate the NPH and regular components—both change together
• Self-mixed NPH + regular insulin allows individual component adjustment, unlike fixed 70/30 2

Dosing complexity:

• 70/30 requires consistent meal timing (must eat within 30-60 minutes of injection due to regular insulin component)
• NPH alone offers more flexibility in meal timing when used purely for basal coverage

Common Pitfalls

1. Don't use 70/30 for basal-only needs—the regular insulin component will cause hypoglycemia without adequate carbohydrate intake
2. Don't assume 1:1 conversion—when transitioning from bedtime NPH to twice-daily regimens, reduce total dose to 80% 2
3. Don't forget meal timing with 70/30—the 30% regular insulin requires food intake to prevent hypoglycemia
4. Monitor for overbasalization—elevated bedtime-to-morning glucose differential or frequent hypoglycemia signals need for regimen change 2

The 2025 ADA guidelines emphasize that when adding prandial insulin to NPH, initiating a premixed insulin plan like 70/30 decreases injection burden 2, making it preferable for patients prioritizing convenience over dosing flexibility.